Developer docs
API playgroundTry for free, no card

Search company profiles

Major Pharmaceuticals

Full company profile

uuid003gagh

Namestring
Major Pharmaceuticals
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Major Pharmaceuticals is a privately held pharmaceutical manufacturer headquartered in Livonia, United States, founded in 2012. Per the firmographic record, the company manufactures both prescription (Rx) and over-the-counter (OTC) pharmaceuticals and operates at a substantial scale, with reported headcount of 10,000+ employees, placing it in the mid-to-large tier of US generic and OTC drug manufacturers. The company's website is majorpharmaceuticals.com, and it operates as a for-profit private entity (no public ticker disclosed).

The available source material does not provide detail on the company's product portfolio, manufacturing sites, distribution channels, customer base, leadership, ownership structure, funding history, or revenue. The aggregated research pull returned content from major-rugby.com, which does not correspond to Major Pharmaceuticals, leaving the operational and financial profile effectively unpopulated beyond the firmographic header. No pricing model, go-to-motion, segment mix, or partnership data is present in the source blocks. As a result, the company's competitive positioning, channel mix (wholesaler vs. direct-to-pharmacy vs. hospital), and geographic footprint beyond the US headquarters cannot be characterized from the supplied evidence.

The core business function — manufacturing and presumably commercializing Rx and OTC pharmaceutical products for downstream healthcare channels — is clear, but the mechanics of how the company goes to market, its regulatory posture, and the depth of its product range are not documented in the input. Any investment assessment based on this data should treat the firmographic facts (Livonia HQ, 2012 founding, 10,000+ employees, Rx+OTC manufacturing) as confirmed and treat all other dimensions as data gaps requiring primary research.

Short descriptiontext

Major Pharmaceuticals is a privately held US pharmaceutical manufacturer headquartered in Livonia, founded in 2012, that produces prescription (Rx) and over-the-counter (OTC) drug products at scale (10,000+ employees) for the US healthcare market.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLivonia, United States
HQ citystring
Livonia
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
generic pharmaceuticals, OTC medications, prescription drugs, pharmaceutical manufacturing, drug distribution
Industry4 codes
1OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief)
CodeCRADAMACPrimaryYes
2Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges)
CodeCRADAMADPrimaryNo
3Pediatric OTC Medicines
CodeHLAIADALPrimaryNo
4Pain Relief & Anti-Inflammatory (Analgesics)
CodeHLAIADAAPrimaryNo
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing32541
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Generic Pharmaceuticals Manufacturing
Social media profiles1 record
Cost components6 values
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Major Pharmaceuticals manufactures prescription (Rx) and over-the-counter (OTC) pharmaceutical products. The company operates as a large-scale drug manufacturer with more than 10,000 employees, headquartered in Livonia, Michigan, United States, producing medicinal products for healthcare distribution channels.

Differentiator
Functional benefit
Problem solved
Product and service2 records
1Prescription (Rx) Pharmaceuticals
2Over-the-Counter (OTC) Pharmaceuticals
CategoryOver-the-Counter Drugs
Description

Over-the-counter pharmaceutical products manufactured by Major Pharmaceuticals and intended for sale through retail and consumer healthcare distribution channels.

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight1 record

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

One of the world's largest generic and biosimilar manufacturers offering both prescription generics and OTC products, comparable in scale, channel mix, and category breadth.

TypeBroad incumbent
Description

Major US pharmaceutical distributor and generics source for retail and hospital channels; an incumbent wholesaler counterpart shaping pricing and demand for generic manufacturers.

TypeDirect peer
Description

Formed from the Mylan-Upjohn merger, Viatris is a major global generics and specialty manufacturer with a broad Rx/OTC product footprint, directly comparable in business model and channel exposure.

TypeBroad incumbent
Description

Major US pharmaceutical wholesaler and parent of Major Pharmaceuticals; broader healthcare distribution and services portfolio makes it a strategically relevant incumbent comparator.

TypeDirect peer
Description

India-based global generic manufacturer with significant US presence across Rx and OTC; comparable as a high-volume, multi-category generic drug producer serving US channels.

TypeDirect peer
Description

Largest generic-pharmaceutical manufacturer globally, producing both Rx and OTC medicines across a broad therapeutic portfolio — the most direct scale and product-mix comparable to Major Pharmaceuticals.

TypeDirect peer
Description

Vertically integrated Indian generic manufacturer with a large US generics franchise, including oral solids, injectables, and OTC products — a comparable scale, model, and product mix.

TypeBroad incumbent
Description

Top-tier US pharmaceutical distributor and key customer of generic manufacturers; comparable as a broad incumbent influencing generic-drug pricing, access, and distribution economics.

TypeDirect peer
Description

Canadian-headquartered generic pharmaceutical manufacturer producing Rx and OTC products for the US and global markets; closely comparable in generic-pharma business model and OTC exposure.

TypeDirect peer
Description

India-based generic manufacturer with substantial US Rx and OTC generics business; comparable in channel dependence, product breadth, and regulatory exposure to the US FDA.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Major Pharmaceuticals

Generic Pharmaceuticals Manufacturingmajorpharmaceuticals.com

Major Pharmaceuticals is a privately held US pharmaceutical manufacturer headquartered in Livonia, founded in 2012, that produces prescription (Rx) and over-the-counter (OTC) drug products at scale (10,000+ employees) for the US healthcare market.

What Major Pharmaceuticals does

Major Pharmaceuticals is a privately held pharmaceutical manufacturer headquartered in Livonia, United States, founded in 2012. Per the firmographic record, the company manufactures both prescription (Rx) and over-the-counter (OTC) pharmaceuticals and operates at a substantial scale, with reported headcount of 10,000+ employees, placing it in the mid-to-large tier of US generic and OTC drug manufacturers. The company's website is majorpharmaceuticals.com, and it operates as a for-profit private entity (no public ticker disclosed).

The available source material does not provide detail on the company's product portfolio, manufacturing sites, distribution channels, customer base, leadership, ownership structure, funding history, or revenue. The aggregated research pull returned content from major-rugby.com, which does not correspond to Major Pharmaceuticals, leaving the operational and financial profile effectively unpopulated beyond the firmographic header. No pricing model, go-to-motion, segment mix, or partnership data is present in the source blocks. As a result, the company's competitive positioning, channel mix (wholesaler vs. direct-to-pharmacy vs. hospital), and geographic footprint beyond the US headquarters cannot be characterized from the supplied evidence.

The core business function — manufacturing and presumably commercializing Rx and OTC pharmaceutical products for downstream healthcare channels — is clear, but the mechanics of how the company goes to market, its regulatory posture, and the depth of its product range are not documented in the input. Any investment assessment based on this data should treat the firmographic facts (Livonia HQ, 2012 founding, 10,000+ employees, Rx+OTC manufacturing) as confirmed and treat all other dimensions as data gaps requiring primary research.

Major Pharmaceuticals firmographics

Firmographics
Name
Major Pharmaceuticals
Website
https://majorpharmaceuticals.com
Company type
Private
Founded year
2012
Headcount range
11–50 employees
Short description
Major Pharmaceuticals is a privately held US pharmaceutical manufacturer headquartered in Livonia, founded in 2012, that produces prescription (Rx) and over-the-counter (OTC) drug products at scale (10,000+ employees) for the US healthcare market.
Ownership category
akta.pro rank

Major Pharmaceuticals industry classification

Industry
Product category
Generic Pharmaceuticals Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)
SIC
Pharmaceutical Preparations (2834)
akta.pro primary industry
OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief) (CRADAMAC)
akta.pro secondary industries
Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), Pediatric OTC Medicines (HLAIADAL), Pain Relief & Anti-Inflammatory (Analgesics) (HLAIADAA)

Keywords

  • Generic pharmaceuticals
  • OTC medications
  • Prescription drugs
  • Pharmaceutical manufacturing
  • Drug distribution

Where Major Pharmaceuticals is headquartered

Location

Headquarters

HQ city
Livonia
HQ country
United States
HQ region
North America

Markets served

Major Pharmaceuticals business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Major Pharmaceuticals product offering

Product offering

Core offering

Major Pharmaceuticals manufactures prescription (Rx) and over-the-counter (OTC) pharmaceutical products. The company operates as a large-scale drug manufacturer with more than 10,000 employees, headquartered in Livonia, Michigan, United States, producing medicinal products for healthcare distribution channels.

Differentiator

Problem solved

Functional benefit

Products and services

  • Prescription (Rx) Pharmaceuticals
  • Over-the-Counter (OTC) Pharmaceuticals Over-the-counter pharmaceutical products manufactured by Major Pharmaceuticals and intended for sale through retail and consumer healthcare distribution channels.

Companies that use Major Pharmaceuticals

Customer profile

Ideal customer profiles1 record

Major Pharmaceuticals technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Major Pharmaceuticals partnerships and signals

Strategic signal

Recent moves1 record

Expansion highlights1 record

Major Pharmaceuticals competitors and assessment

Company assessment

Direct peers

  • Sandoz (Novartis): One of the world's largest generic and biosimilar manufacturers offering both prescription generics and OTC products, comparable in scale, channel mix, and category breadth.
  • Viatris: Formed from the Mylan-Upjohn merger, Viatris is a major global generics and specialty manufacturer with a broad Rx/OTC product footprint, directly comparable in business model and channel exposure.
  • Sun Pharmaceutical Industries: India-based global generic manufacturer with significant US presence across Rx and OTC; comparable as a high-volume, multi-category generic drug producer serving US channels.
  • Teva Pharmaceutical Industries: Largest generic-pharmaceutical manufacturer globally, producing both Rx and OTC medicines across a broad therapeutic portfolio — the most direct scale and product-mix comparable to Major Pharmaceuticals.
  • Aurobindo Pharma: Vertically integrated Indian generic manufacturer with a large US generics franchise, including oral solids, injectables, and OTC products — a comparable scale, model, and product mix.
  • Apotex: Canadian-headquartered generic pharmaceutical manufacturer producing Rx and OTC products for the US and global markets; closely comparable in generic-pharma business model and OTC exposure.
  • Lupin Pharmaceuticals: India-based generic manufacturer with substantial US Rx and OTC generics business; comparable in channel dependence, product breadth, and regulatory exposure to the US FDA.

Broad incumbents

  • Cardinal Health: Major US pharmaceutical distributor and generics source for retail and hospital channels; an incumbent wholesaler counterpart shaping pricing and demand for generic manufacturers.
  • McKesson Corporation: Major US pharmaceutical wholesaler and parent of Major Pharmaceuticals; broader healthcare distribution and services portfolio makes it a strategically relevant incumbent comparator.
  • AmerisourceBergen (Cencora): Top-tier US pharmaceutical distributor and key customer of generic manufacturers; comparable as a broad incumbent influencing generic-drug pricing, access, and distribution economics.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights4 records

Customer concentration

Major Pharmaceuticals social profiles

Digital presence

Major Pharmaceuticals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Major Pharmaceuticals leadership team

Management profile

Number of profiles

Major Pharmaceuticals funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Major Pharmaceuticals M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Major Pharmaceuticals

What does Major Pharmaceuticals do?

Major Pharmaceuticals manufactures prescription (Rx) and over-the-counter (OTC) pharmaceutical products. The company operates as a large-scale drug manufacturer with more than 10,000 employees, headquartered in Livonia, Michigan, United States, producing medicinal products for healthcare distribution channels.

When was Major Pharmaceuticals founded?

Major Pharmaceuticals was founded in 2012. It employs 11 to 50 people.

Where is Major Pharmaceuticals based?

Major Pharmaceuticals is headquartered in Livonia, United States, in the North America region.

Who are Major Pharmaceuticals's main competitors?

Direct peers on record are Sandoz (Novartis), Viatris, Sun Pharmaceutical Industries, Teva Pharmaceutical Industries, Aurobindo Pharma, Apotex and Lupin Pharmaceuticals. Broad incumbents are Cardinal Health, McKesson Corporation and AmerisourceBergen (Cencora).

Does Major Pharmaceuticals have an API?

No public API is recorded for Major Pharmaceuticals.

What industry is Major Pharmaceuticals in?

Major Pharmaceuticals's product category is Generic Pharmaceuticals Manufacturing. Its primary akta.pro industry code is CRADAMAC, OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief), with a secondary code of CRADAMAD, Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AL.comThyroid medication recalled nationwide for over potency concernsMajor Pharmaceuticals is recalling 12 versions of levothyroxine sodium tablets nationwide after testing revealed insufficient active ingredient levels in the medication. The FDA classified the recall as Class II, indicating it may cause temporary or medically reversible health consequences for patients. The affected products span seven dosage strengths in two packaging formats distributed both directly by Major Pharmaceuticals and through co-distributor Cardinal Health.AOL.comPopular Thyroid Medication Nationwide, FDA WarnsThe FDA has initiated a nationwide Class II recall for specific lots of levothyroxine sodium tablets distributed by Major Pharmaceuticals, after tablets were found to be subpotent, meaning they deliver less medication than intended. The affected medication, used to treat hypothyroidism and goiter, was packaged in 10-count blister packs across multiple dosage strengths (25 mcg to 150 mcg) with various lot numbers and expiration dates through 2027. Patients with affected medication are advised to consult their pharmacist or doctor before discontinuing use, as suddenly stopping thyroid medication can cause adverse effects.PR NewswireFDA announces voluntary recall of several medicines containing valsartan following detection of an impurityThe U.S. Food and Drug Administration announced a voluntary recall of several medicines containing valsartan, used to treat high blood pressure and heart failure, after detecting N-nitrosodimethylamine (NDMA), a probable human carcinogen. The recall affects products from Major Pharmaceuticals, Solco Healthcare, and Teva Pharmaceuticals Industries Ltd., which supplied valsartan from a third-party manufacturer where the impurity was introduced during production changes. The FDA is investigating the levels of NDMA in affected products, assessing patient impact, and working with the companies to eliminate the impurity from future batches while ensuring adequate supply of unaffected alternatives.GlobeNewswireFollowing a successful year, DIAGNOS Announces a One-Year Agreement in United Arabs Emirates with a Major Pharmaceutical CompanyDIAGNOS Inc. signed a one-year turnkey screening contract in the United Arab Emirates with a major pharmaceutical company. The agreement is expected to screen an additional 2,500 patients using its CARA tele-ophthalmology platform. The company has previously rendered healthcare services in 16 countries.PR NewswireFDA warns of potential contamination in multiple brands of drugs, dietary supplementsThe U.S. Food and Drug Administration advised consumers and health care professionals on August 11, 2017, not to use any liquid drug or dietary supplement products manufactured by PharmaTech LLC of Davie, Florida, and distributed by Rugby Laboratories, Major Pharmaceuticals and Leader Brands, due to potential contamination with Burkholderia cepacia bacteria and the risk for severe patient infection. The contaminated products include liquid docusate sodium drugs (stool softeners) and various liquid vitamin supplements marketed for infants and children, which were distributed nationwide to retailers, health care facilities, pharmacies and online. The warning follows CDC laboratory testing that detected a strain of B. cepacia linked to recent patient infections, and follows a similar advisory issued in 2016.GlobeNewswireMajor Pharma Company Chooses Provision to Promote Consumer Healthcare BrandA major pharmaceutical company began a national advertising campaign on Provision's 3D Savings Center kiosks, promoting a consumer health brand. The campaign uses 3D holographic technology and in-store coupons across U.S. retail locations. Provision's CEO said the client's commitment shows confidence in the platform to generate awareness at point-of-sale.